Botox is one of the most extensively studied dermatology treatments and is approved for cosmetic use in 78 countries. The safety and efficacy of Botox have been evaluated in many clinical trials, including more than 400 peer-reviewed articles in scientific and medical journals. Many of these trials were performed here at the Laser & Skin Surgery Center of New York within our research department.

The Laser & Skin Surgery Center of New York offers Dysport, Xeomin, and Jeuveau to our patients as other effective alternatives in anti-aging and rejuvenation. 

Daxxify is a new neuromodulator that treats dynamic wrinkles formed from repetitive facial expressions like smiling, frowning, and laughing. The treatment works in a similar fashion to Botox or other neuromodulators, but results may last up to 6-9 months in some patients. Revance, the maker of Daxxify, is a biotechnology company focusing on aesthetic and therapeutic treatments and has created other notable injectable treatments like RHA dermal fillers.

Learn more about Daxxify.

Xeomin is another product that falls into the category of neuromodulators, along with Botox, Dysport, and the latest addition, Jeuveau. Dermatologists use neuromodulators to minimize the appearance of some types of wrinkles, including crow’s feet, frown lines, and horizontal forehead wrinkles.

Xeomin was FDA-approved for cosmetic use after two US clinical trials showed it was comparable in both safety and efficacy to Botox. The US was the 20th country to approve the product as a wrinkle treatment. Before that time, Xeomin was approved as a medical treatment for some muscle and nerve conditions.

Learn more about Xeomin.

All of our physicians at the Laser & Skin Surgery Center of New York have extensive experience with Botox and wrinkle treatments. We are leaders in the field of cosmetic dermatology and the largest users of fillers and injectables in the world. Schedule an appointment with us today.